Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
Halozyme pulls Evotec bid after biotech was 'unwilling' to talk
Halozyme leaders tried to meet with the chairwoman of Evotec’s supervisory board, Iris Löw-Friedrich, M.D., Ph.D., but were rebuffed.
Darren Incorvaia
Nov 22, 2024 10:46am
Genmab open to more M&A if it makes 'strategic sense,’ CFO says
Nov 21, 2024 1:05pm
Novartis signs $1.1B deal for muscular dystrophy biotech
Nov 21, 2024 8:19am
Halozyme offers $2B for Evotec to expand beyond tech used by J&J
Nov 15, 2024 6:01am
BioNTech pays $800M to take control of potential Keytruda killer
Nov 13, 2024 6:45am
Evotec attracts private equity buyout interest: report
Nov 11, 2024 9:17am
